Fidelity Investments’s IGC Pharma IGC Stock Holding History

Fidelity Investments’s Portfolio IGC Stock Details IGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-5	Closed	-$2	–	5494
2025 Q3	$2	Sell	5 -103	-95%	-$39	﹤0.01%	5356
2025 Q2	$33	Buy	108 +103	+2,060%	+$31	﹤0.01%	5208
2025 Q1	$1	Sell	5 -37	-88%	-$12	﹤0.01%	5273
2024 Q4	$14	Buy	+42	New	+$16	﹤0.01%	5413
2024 Q3	–	Sell	-36	Closed	-$15	–	5606
2024 Q2	$15	Sell	36 -2,715	-99%	-$1.35K	﹤0.01%	5240
2024 Q1	$1.1K	Buy	2,751 +2,595	+1,663%	+$806	﹤0.01%	4771
2023 Q4	$44	Buy	+156	New	+$48	﹤0.01%	5046
2022 Q4	–	Sell	-300	Closed	–	–	5470
2022 Q3	$0	Buy	+300	New	+$160	﹤0.01%	5146
2020 Q4	–	Sell	-234	Closed	–	–	4064
2020 Q3	$0	Buy	+234	New	+$238	﹤0.01%	3836
2019 Q4	–	Sell	-60	Closed	–	–	4015
2019 Q3	$0	Sell	60 -107	-64%	-$129	﹤0.01%	3994
2019 Q2	$0	Buy	+167	New	+$236	﹤0.01%	3952

Other funds holding IGC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Dearborn Partners Chicago, Illinois $1.85B AUM 6.59% 1-Year Est. Return

Lawood & Co Williamsport, Pennsylvania $148M AUM

Fidelity Investments's IGC Position: Q4 2025 in Review

Fidelity Investments sold out of IGC Pharma (IGC) in Q4 2025, closing a stake of 5 shares — an estimated $2 sold.

Fidelity Investments first reported a position in IGC in Q2 2019 and held it in 11 quarters. The position peaked at $1.1K in Q1 2024. 30 funds tracked by Wall St. Rank hold IGC as of Q4 2025.

Fidelity Investments reported no remaining IGC Pharma position as of Q4 2025 after selling out during the quarter.
Fidelity Investments sold 5 IGC Pharma shares in Q4 2025, an estimated $2.
Fidelity Investments first reported a position in IGC Pharma in Q2 2019 and held it in 11 quarters.
Fidelity Investments's IGC Pharma position peaked at $1.1K in Q1 2024.
30 funds tracked by Wall St. Rank held IGC Pharma as of Q4 2025.

Based on Fidelity Investments's 13F filing for Q4 2025, filed 17 Feb 2026.